OncoSenX
OncoSenX is a Seattle-based biotech startup developing lipid nanoparticle gene-delivery therapeutics designed to kill cancer cells based...
Facts
- HQ
- Seattle
- Sectors
- Biotechnology, Therapeutics
- Stage
- Seed
- Total raised
- $4.8M SEC Form D filings Total of this company's SEC Form D filings
- Last round
- $650K · Jul 2021 SEC Form D
OncoSenX extends oversubscribed SAFE, plans $30M Series A to fund Phase I for genetics-targeted cancer therapies
Seattle biotech OncoSenX extended an oversubscribed SAFE to raise more capital for its lipid nanoparticle gene-delivery cancer therapies and plans a $30 million Series A to fund a Phase I trial; the spinout has raised $4.1 million so far and has six employees.
